NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 24 03:31PM ET
14.28
Dollar change
+1.52
Percentage change
11.91
%
Index- P/E- EPS (ttm)-13.81 Insider Own19.06% Shs Outstand6.58M Perf Week5.00%
Market Cap94.01M Forward P/E- EPS next Y-3.46 Insider Trans0.00% Shs Float5.33M Perf Month89.89%
Enterprise Value48.15M PEG- EPS next Q-1.18 Inst Own70.32% Short Float3.25% Perf Quarter125.95%
Income-43.71M P/S- EPS this Y61.77% Inst Trans-8.99% Short Ratio3.13 Perf Half Y-23.84%
Sales0.00M P/B2.45 EPS next Y25.74% ROA-110.01% Short Interest0.17M Perf YTD-37.12%
Book/sh5.84 P/C2.05 EPS next 5Y41.96% ROE-130.27% 52W High28.68 -50.21% Perf Year14.24%
Cash/sh6.97 P/FCF- EPS past 3/5Y32.09% 24.08% ROIC-113.76% 52W Low4.11 247.45% Perf 3Y-52.00%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility13.41% 11.23% Perf 5Y-96.53%
Dividend TTM- EV/Sales- EPS Y/Y TTM45.19% Oper. Margin- ATR (14)1.80 Perf 10Y-
Dividend Ex-Date- Quick Ratio5.22 Sales Y/Y TTM- Profit Margin- RSI (14)64.53 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio5.22 EPS Q/Q65.88% SMA2024.36% Beta2.89 Target Price48.67
Payout- Debt/Eq0.00 Sales Q/Q- SMA5063.47% Rel Volume0.74 Prev Close12.76
Employees14 LT Debt/Eq0.00 EarningsMay 15 AMC SMA20037.29% Avg Volume55.32K Price14.28
IPOApr 13, 2017 Option/ShortNo / Yes EPS/Sales Surpr.-44.21% - Trades Volume37,967 Change11.91%
Date Action Analyst Rating Change Price Target Change
Jan-21-25Initiated TD Cowen Buy
Apr-08-24Upgrade Ladenburg Thalmann Neutral → Buy $2.75
Sep-20-21Upgrade Chardan Capital Markets Sell → Buy $4 → $3.50
Sep-03-21Downgrade Truist Buy → Hold $4
Sep-03-21Downgrade Ladenburg Thalmann Buy → Neutral
Sep-03-21Downgrade Chardan Capital Markets Buy → Sell $105 → $4
Sep-03-21Downgrade B. Riley Securities Buy → Neutral $3
May-14-21Initiated B. Riley Securities Buy $73
Mar-26-21Initiated Citigroup Buy $75
Aug-28-20Upgrade Chardan Capital Markets Neutral → Buy $45
Today 01:06PM
Jun-23-25 07:18AM
May-15-25 04:01PM
Apr-03-25 12:00PM
Mar-31-25 09:00AM
09:00AM Loading…
Feb-03-25 09:00AM
Nov-25-24 09:00AM
09:00AM
Nov-20-24 09:00AM
Nov-14-24 04:01PM
Aug-26-24 11:51AM
Aug-14-24 09:54PM
04:01PM
Jul-15-24 10:26AM
09:35AM
04:05PM Loading…
May-17-24 04:05PM
May-13-24 09:54PM
04:05PM
Mar-25-24 12:00PM
Mar-19-24 06:53AM
Mar-18-24 04:05PM
Dec-04-23 07:21AM
Dec-01-23 04:01PM
Nov-13-23 04:01PM
Sep-14-23 10:50AM
Sep-06-23 03:15PM
Aug-25-23 08:00AM
Aug-14-23 04:01PM
Aug-01-23 04:01PM
Jun-20-23 08:00AM
04:01PM Loading…
May-19-23 04:01PM
May-15-23 04:01PM
Mar-31-23 04:05PM
Jan-12-23 04:05PM
Nov-14-22 04:01PM
04:01PM
Aug-17-22 08:00AM
Aug-15-22 04:05PM
Jul-08-22 07:16AM
Jun-07-22 09:00AM
09:00AM
May-16-22 09:00AM
Dec-15-21 05:55AM
Sep-09-21 06:15PM
Sep-08-21 08:51AM
Sep-07-21 09:40PM
Sep-06-21 12:42PM
Sep-03-21 07:42PM
02:14PM
11:15AM
Sep-02-21 04:05PM
Aug-16-21 04:05PM
Aug-02-21 04:01PM
Jul-12-21 04:01PM
Jul-07-21 10:02AM
Jul-01-21 04:01PM
May-14-21 03:06AM
May-10-21 04:05PM
02:30PM
May-03-21 04:30PM
Mar-25-21 08:42AM
Mar-24-21 08:00AM
06:30AM
Mar-17-21 04:05PM
Feb-23-21 04:01PM
Feb-18-21 04:01PM
Feb-13-21 03:18AM
Feb-12-21 04:01PM
Dec-02-20 11:26PM
Nov-24-20 04:05PM
Nov-16-20 04:05PM
Nov-15-20 09:00AM
Nov-10-20 04:05PM
Nov-09-20 04:05PM
02:30PM
Nov-02-20 04:30PM
04:05PM
Oct-29-20 08:00AM
Oct-28-20 04:09PM
Oct-26-20 08:30AM
Sep-29-20 09:00AM
Sep-16-20 08:48AM
Sep-09-20 04:01PM
Aug-25-20 08:30AM
Aug-10-20 04:00PM
Aug-03-20 09:00AM
Jul-28-20 08:30AM
Jun-18-20 08:30AM
Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The firm's lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner in 2017 and is headquartered in Dallas, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Riley Antony ACHIEF FINANCIAL OFFICERApr 01 '25Option Exercise0.00375031,372Apr 02 05:03 PM
Wagner Paul A.SEE REMARKSApr 01 '25Option Exercise0.001,250079,806Apr 02 05:01 PM
Riley Antony ACHIEF FINANCIAL OFFICERJan 01 '25Option Exercise0.00375031,151Jan 02 05:10 PM
Wagner Paul A.SEE REMARKSJan 01 '25Option Exercise0.001,250078,720Jan 02 05:09 PM
Riley Antony ACHIEF FINANCIAL OFFICERNov 21 '24Buy5.5522,514124,99830,776Nov 22 05:45 PM
Riley Antony ACHIEF FINANCIAL OFFICEROct 01 '24Option Exercise0.0037508,395Oct 02 06:21 PM
Wagner Paul A.SEE REMARKSOct 01 '24Option Exercise0.001,250077,568Oct 02 06:19 PM
Riley Antony ACHIEF FINANCIAL OFFICERJul 01 '24Option Exercise0.009,3750203,849Jul 03 12:18 PM
Wagner Paul A.SEE REMARKSJul 01 '24Option Exercise0.0031,25001,910,424Jul 03 12:17 PM